Affected by the continuous fermentation of monkeypox epidemic abroad, recently, the share prices of a number of biological vaccine enterprises in a share rose sharply. For example, Shanghai Zj Bio-Tech Co.Ltd(688317) has increased by 16.34% and 20% respectively in the last two trading days Changchun Bcht Biotechnology Co(688276) 5 rose 15.57% on May 20 and rose 13.47% again today.
On May 23, Shanghai Zj Bio-Tech Co.Ltd(688317) , Changchun Bcht Biotechnology Co(688276) and other companies responded to the stock price changes and explained the effect of the company’s products on monkeypox virus.
several companies responded to monkeypox products
On May 23, affected by the news of overseas monkeypox epidemic, the share prices of A-share related companies rose sharply among them, Shanghai Zj Bio-Tech Co.Ltd(688317) and youningwei increased the limit, Sansure Biotech Inc(688289) increased by 15.84%, and individual stocks such as West Point pharmaceutical, Changchun Bcht Biotechnology Co(688276) , Nanjing Hicin Pharmaceutical Co.Ltd(300584) increased by more than 10%
On May 23, Shanghai Zj Bio-Tech Co.Ltd(688317) , Changchun Bcht Biotechnology Co(688276) and other companies responded to the rise in share prices and monkeypox related products.
Shanghai Zj Bio-Tech Co.Ltd(688317) said that the World Health Organization recently reported that more than 12 countries have reported about 80 cases of monkeypox virus. The monkeypox virus nucleic acid assay kit (fluorescent PCR method) independently developed and produced by the company has been certified by EU CE, which can help diagnose and prevent related diseases.
Previously, Shanghai Zj Bio-Tech Co.Ltd(688317) said on the interactive platform that the monkeypox virus nucleic acid assay kit had received small orders from China and abroad. The product introduction of the kit is also available on Shanghai Zj Bio-Tech Co.Ltd(688317) official website. The company said that by specifically detecting the nucleic acid fragment of monkeypox virus, the kit can be used for clinical or scientific diagnosis of related diseases caused by monkeypox virus infection.
The Changchun Bcht Biotechnology Co(688276) price of main products including varicella vaccine continued to rise sharply in the past two trading days. On May 23, Changchun Bcht Biotechnology Co(688276) announced that it had noticed that some media had published reports about monkeypox virus infection cases in many countries and listed companies with monkeypox virus related products or technical reserves.
Changchun Bcht Biotechnology Co(688276) said that the company’s varicella vaccine could not prevent monkeypox, and the company currently had no products related to monkeypox virus prevention. On the interactive platform, Changchun Bcht Biotechnology Co(688276) gave a more detailed explanation.
Changchun Bcht Biotechnology Co(688276) said that monkeypox virus and smallpox virus belong to the genus orthopox virus of poxviridae, which is a viral zoonosis. This virus can be transmitted from animals to people through direct close contact or between people. The transmission routes mainly include blood and body fluids. Monkeypox is far less infectious than smallpox virus.
varicella zoster virus belongs to herpesvirus family. There is no animal storage host. Human is the only natural host, which is transmitted through respiratory tract. The company’s varicella vaccine can not prevent monkeypox, and there are no products related to the prevention of monkeypox virus
The share price of Western pharmaceutical industry has also risen sharply in recent two days. On May 23, an investor asked West Point pharmaceutical that acyclovir was recommended for the treatment of monkeypox. Does the company have any antiviral drugs for monkeypox? In response, the company responded that the acyclovir tablets produced by the company can be used for the treatment of chickenpox in people with immune deficiency.
several companies plan to promote the registration of monkeypox related products
With the increasing number of confirmed cases of monkeypox overseas, recently, many investors on the interactive platform asked relevant listed companies about the development progress of monkeypox related products.
In this regard, Daan Gene Co.Ltd(002030) may 23 said that the company has reserves of monkeypox virus related scientific research products and can provide “monkeypox virus nucleic acid detection kit (PCR fluorescent probe method)” scientific research products to disease control, entry-exit quarantine and epidemic prevention and overseas medical and health institutions. However, there is no relevant certified reagent at present, which will not have an impact on the current revenue and profit of the company.
Daan Gene Co.Ltd(002030) said that it would promote the Chinese registration of the product according to the relevant policies of the State Food and drug administration, and the company had started the EU CE registration of the product.
3 Longxing Chemical Stock Co.Ltd(002442) 3 said that the company’s laboratory has the ability to detect monkeypox virus, and the product monkeypox virus nucleic acid determination kit developed by its subsidiary Dean biology is applying for EU CE certification.
Jiangsu Bioperfectus Technologies Co.Ltd(688399) said that the company’s product line has monkeypox virus nucleic acid detection kit (fluorescence PCR method), which is sold in the disease control and scientific research market. In recent years, the product has been sold in a small amount in some CDC, customs, scientific research institutes and other institutions outside China. At the same time, the company has started the overseas registration of the product, including EU CE.
Anhui Anke Biotechnology (Group)Co.Ltd(300009) said that the recent monkeypox virus epidemic has attracted attention from all parties. The company is also paying close attention to the epidemic situation, actively promoting the R & D and reserve of monkeypox virus nucleic acid detection kit, and will decide whether to further promote the R & D of relevant products according to the follow-up situation.
Guangdong Hybribio Biotech Co.Ltd(300639) said that the company has the laboratory detection ability of monkeypox virus and has formed laboratory products that can be used for scientific research. The company will continue to pay attention to the dynamics of this matter.
15 countries have reported confirmed cases
At present, the overseas monkeypox epidemic is still fermenting. According to the information released by the World Health Organization, as of May 22 local time, 108 confirmed cases and 91 suspected cases had been reported to 14 non monkeypox endemic countries and regions. With the expansion of monitoring scope, it is expected that more monkeypox cases will appear in the world.
As of May 22 local time, Israel, Switzerland and Austria have also reported confirmed cases of monkeypox in the past two days, and the number of countries reporting confirmed cases has increased to 15, CCTV quoted the BBC as saying. In addition, the United States, the United Kingdom and other countries that have found monkeypox cases have recently reported the discovery of new confirmed or suspected cases.
On May 23, according to the microblog of Russian satellite news agency, the Argentine Ministry of health released a news that a resident of Buenos Aires Province was suspected to be infected with monkeypox. On the whole, the patient is in good condition and is receiving treatment. It is reported that the patient has been to Spain.
For the spread of monkeypox, the who said that the available information showed that interpersonal transmission was taking place among people in close physical contact with symptomatic cases.
